Clinical trial · Observational
Prediction of Lymph Node Status in Stage T1 Esophageal Squamous Cell Carcinoma（RENMIN-237）
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Accurate assessment of lymph node status in superficial esophageal squamous cell carcinoma is of great significance for preventing undertreatment and overtreatment. However, the accuracy of the commonly used preoperative imaging methods for evaluating lymph node status is not high, and it is urgent to develop a prediction model that can predict the risk of individual lymph node metastasis to assist in clinical decision-making. In this context, investigators intend to retrospectively collect the clinical and pathological data of 300 patients with superficial esophageal squamous cell carcinoma, construct a lymph node metastasis risk prediction model. In addition, investigators are also preparing to prospectively collect tissue samples from 30 patients with superficial esophageal squamous cell carcinoma to further explore the mechanism of lymph node metastasis.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Esophageal Squamous Cell Carcinoma | Esophageal Squamous Cell Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| no intervention | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Lymph node metastasis negative
- description
- Superficial esophageal squamous cell carcinoma with negative lymph node metastasis
- label
- Lymph node metastasis positive
- description
- Superficial esophageal squamous cell carcinoma with positive lymph node metastasis
- interventionNames
- Other: no intervention
Primary outcomes (1)
- measure
- Lymphatic metastases
- timeFrame
- Through study completion, an average of 2 year
- description
- The primary end point was the presence of lymph node metastases in surgically resected specimens (≥ 15 resected lymph nodes), or the development of metastases during follow-up including local recurrence and distant metastasis (AJCC 8th). In cases of an endoscopic resection prior to surgical resection, the tumor was found in the endoscopic resection specimen and lymph node status in the surgical resection specimen. When no additional surgery was performed after endoscopic resection, the development of metastases during follow-up was used as a surrogate end point.
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: 1. Patients diagnosed with esophageal cancer in Renmin Hospital of Wuhan University from 2013 to 2022. 2. Histopathological diagnosis was squamous cell carcinoma. 3. T1NxM0. 4. Received endoscopic resection or esophagectomy. Exclusion Criteria: 1. Patients who received neoadjuvant therapy. 2. Positive surgical margin. 3. Prior malignancy requiring active treatment within the previous 3 years except for locally curable cancers that have been apparently cured. 4. Lack of complete histopathological information.
References
Publications (0)
Data not yet available